| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5198735
Max Phase: Preclinical
Molecular Formula: C21H14FN5O2
Molecular Weight: 387.37
Associated Items:
Representations
Canonical SMILES: N#Cc1cn(Cc2cccc(F)c2)c2ccc(NC(=O)c3cc(=O)[nH]cn3)cc12
Standard InChI: InChI=1S/C21H14FN5O2/c22-15-3-1-2-13(6-15)10-27-11-14(9-23)17-7-16(4-5-19(17)27)26-21(29)18-8-20(28)25-12-24-18/h1-8,11-12H,10H2,(H,26,29)(H,24,25,28)
Standard InChI Key: OJRUYMAILFLBGB-UHFFFAOYSA-N
Associated Targets(Human)
Xanthine dehydrogenase 1038 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 387.37 | Molecular Weight (Monoisotopic): 387.1132 | AlogP: 3.04 | #Rotatable Bonds: 4 |
| Polar Surface Area: 103.57 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 8.36 | CX Basic pKa: | CX LogP: 2.55 | CX LogD: 2.51 |
| Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.56 | Np Likeness Score: -2.12 |
References
| 1. Zhang B, Duan Y, Yang Y, Mao Q, Lin F, Gao J, Dai X, Zhang P, Li Q, Li J, Dai R, Wang S.. (2022) Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors., 227 [PMID:34688012] [10.1016/j.ejmech.2021.113928] |
Source
Source(1):